Related Experiment Video

Updated: May 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

How to optimize HCV therapy in genotype 4 patients

Gamal Esmat1, Mohamed El Kassas, Mohamed Hassany

  • 1Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt. gesmat@gamalesmat.com

Liver International : Official Journal of the International Association for the Study of the Liver
|January 5, 2013
PubMed

Insights

Hepatitis C virus (HCV) infection is a global health concern, particularly prevalent in Africa and the Middle East. Optimizing treatment requires considering viral, host, and comorbidity factors for best patient outcomes.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) affects 3% of the global population, with significant prevalence in Africa and the Middle East, notably Egypt.
  • HCV genotype 4 (HCV4) poses a specific challenge in these regions.

Purpose of the Study:

  • To outline the multifaceted factors influencing Hepatitis C virus 4 treatment efficacy.
  • To emphasize the importance of personalized treatment strategies for optimizing patient outcomes.

Main Methods:

  • Review of factors affecting HCV treatment, encompassing viral characteristics, host-related elements, comorbidities, and therapeutic interventions.
  • Analysis of viral genotype, pretreatment viral load, quasispecies, host genetics, age, ethnicity, liver histology, obesity, insulin resistance, and co-infections.

Main Results:

  • HCV treatment success is contingent upon a complex interplay of viral, host, and comorbidity factors.
  • Therapeutic drug choice, dosage, and duration are critical determinants of treatment outcomes.

Conclusions:

  • Effective management of Hepatitis C virus 4 necessitates a comprehensive approach, addressing all contributing factors.
  • Personalized treatment optimization is crucial for achieving the best possible results for patients with HCV infection.

More Related Videos

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...